Alere (NYSE: ALR) announced that its Alere™ HIV Combo, a rapid point-of-care fourth-generation test that detects both HIV-1/2 antibodies and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE